Monday, April 16, 2018

NPR Notícias de negócios: Merck Immunotherapy Drug Shines In Lung Cancer Study

Merck Immunotherapy Drug Shines In Lung Cancer Study
Research finds that more than two-thirds of lung cancer patients who received Keytruda plus chemotherapy would be alive a year later, compared with about half of people who only got chemotherapy.

leia mais em NPR

No comments:

Post a Comment